Chirana T.Injecta,A.S. · Class II · Cleared Apr 17, 2026
| K-number | K252279 |
| Device name | Sterile Hypodermic Syringe for Single Use (20ml, 30ml, 50ml, 60ml) |
| Applicant | Chirana T.Injecta,A.S. |
| Product code | FMF |
| Device class | Class II |
| Decision date | Apr 17, 2026 |
| Decision | Substantially Equivalent |
| Regulation | 880.5860 |
The Sterile Hypodermic Syringe for Single Use is a medical injection and withdrawal device available in 20ml, 30ml, 50ml, and 60ml sizes. It consists of a polypropylene barrel and piston, a latex-free synthetic rubber gasket, and medical-grade silicone lubricant, with graduated milliliter markings for dose control.
The device features a barrel, plunger, and piston made of polypropylene with polydimethylsiloxane lubricant. It includes Luer Lock (centric cone) and Luer Slip (50ml eccentric cone) connectors manufactured per EN ISO 80369-7:2021. The subject device omits the 10ml size offered in the predicate and has slightly different cone placement specifications, but otherwise maintains identical design, materials, and structural support mechanisms.
ISO 7886-1:2017 and 2018 (syringe performance), ISO 80369-7:2021 (Luer connectors), EN 868-5:2018 (seal strength), EN ISO 11607-2:2020 (sterile barrier), ISO 10993-5 (cytotoxicity), ISO 10993-10 (skin sensitization, irritation, intracutaneous reactivity), ISO 10993-11 (pyrogenicity, acute systemic toxicity), ISO 10993-4:2017 (hemocompatibility), and USP 151 (pyrogenicity).
The subject device is substantially equivalent to predicate K213811 because it shares identical indications for use, design components, materials, connector types, prescription-use classification, single-use status, performance standards, biocompatibility, 5-year shelf-life, and sterilization method (ethylene oxide to SAL 10^-6). Minor differences—the omission of a 10ml size and slight cone placement variations—represent reduced product offerings and design conventions consistent with established syringe standards that do not raise new safety or effectiveness questions.
View the full FDA submission: accessdata.fda.gov